SEGMENT REPORTING AND FOREIGN OPERATIONS - Operating Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 1,515,906	$ 1,356,514	$ 1,257,366
Selling, general and administrative expenses	455,214	399,731	373,676
Income from operations	184,720	155,693	123,944
Total other expense - net	(13,783)	(5,700)	(11,855)
Income before income taxes	170,937	149,993	112,089
Cardiovascular
Segment Reporting Information [Line Items]
Net sales	1,443,042	1,301,744	1,220,560
Cost of sales standard	576,864	549,657	534,826
Cost of sales other	173,686	140,948	125,388
Selling, general and administrative expenses	431,252	376,734	362,082
Research and development expenses	94,157	83,812	80,300
Other operating expenses	950	443	3,524
Income from operations	166,133	150,150	114,440
Endoscopy
Segment Reporting Information [Line Items]
Net sales	72,864	54,770	36,806
Cost of sales standard	18,067	15,746	12,987
Cost of sales other	9,019	6,830	293
Selling, general and administrative expenses	23,962	22,997	11,594
Research and development expenses	3,195	3,654	2,428
Other operating expenses	34
Income from operations	$ 18,587	$ 5,543	$ 9,504